MTBDR-RIF 9G Membrane Kit(TM)/Test kit
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- molecular biology, tuberculosis
- Category
- Medical Devices , Medical Test Kit
Biometrix Technology Co, Ltd
- Country / Year Established
- South Korea / 2000
- Business type
- Manufacturer
- Verified Certificate
-
4
Product name | MTBDR-RIF 9G Membrane Kit(TM)/Test kit | Certification | - |
---|---|---|---|
Category |
Medical Devices
Medical Test Kit |
Ingredients | - |
Keyword | molecular biology , tuberculosis | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | - |
Product Information
• TB decreases below 10,000 CFU/ml in 1 to 2 months after starting treatment
• TB during treatment is reduced to 10,000 CFU/ml or less, and MTBDR-RIF test is only available for BMT products.
• WHO’s guidelines recommend cross -validation with more than one test method.
• BMT MTBDR-RIF 9G Membrane KIT can continuously track up to 10 CFU/ml.
• BMT products are the only ones that can be used with cell culture (DST) -> Can increase reliability of test results.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
Biometrix Technology Co, Ltd
- Country / Year Established
- South Korea / 2000
- Business type
- Manufacturer
-
4
- President
- KIM TAE SEON
- Address
- Soyanggangro 56 Bioventureplaza 2 2 ho , Chuncheon-si, Gangwon-do, Korea
- Product Category
- Medical Test Kit,Other Monitoring & Diagnostic Equipment
- Year Established
- 2000
- No. of Total Employees
- 1-50
- Company introduction
-
Biometrix Technology. Inc. has developed the world’s first 9G technology that arranges 9 guanine bases at regular intervals in a molecular recognition format and DAGON technology that can detect marker proteins up to a pg/ml level. Based on this core technology, we have established a platform technology applicable to the detection of various genes and proteins, and based on this, we sell IVD diagnostic devices and reagents. Using this technology, Biometrix Technology has entered into the market for cardiovascular disease prevention and management by using cardiovascular monitoring products to easily manage cardiovascular diseases. In addition, we are working hard to lead the field of early cancer screening molecular diagnostics that no one has entered the market yet. Biometrix Technology continues to showcase the world’s leading cardiovascular and early-stage cancer molecular diagnostic reagents and hopes to become the world’s leading professional healthcare company.
- Main Product
Related Products
Hairview
DISSECTING MEDICAL STUDENT KIT ANATOMY BIOLOGY STAINLESS
Dental Implant Ratchet Hex Drivers
DENCLE ANDANTE FUNCTIONAL TOOTHBRUSH_10 Pieces
Pentagon Grand (CO2 fractional laser)